{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:29:55Z","timestamp":1792718995307,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.oret.2025.02.013","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:28:24Z","timestamp":1739791704000},"page":"798-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes"],"prefix":"10.1016","volume":"9","author":[{"given":"Luiz F.","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla R.P.D.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7250-3086","authenticated-orcid":false,"given":"Jos\u00e9 R.F.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique K.","family":"Mangeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno A.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-9323","authenticated-orcid":false,"given":"Ricardo","family":"Casaroli-Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-4447","authenticated-orcid":false,"given":"Juliana M.F.","family":"Sallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.02.013_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","article-title":"The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma","volume":"9","author":"Yamane","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.oret.2025.02.013_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.013_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145436","article-title":"Advanced unilateral retinoblastoma: the impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC","volume":"10","author":"Abramson","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"Munier","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4103\/ijo.IJO_866_19","article-title":"Intra-arterial chemotherapy in retinoblastoma \u2013 a paradigm change","volume":"67","author":"Manjandavida","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.013_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000511980","article-title":"Eye salvage with intra-arterial and intra-vitreal chemotherapy in patients with retinoblastoma: 8-year single-institution experience in Colombia","volume":"7","author":"Gonz\u00e1lez","year":"2021","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.oret.2025.02.013_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27086","article-title":"Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina","volume":"65","author":"Funes","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.oret.2025.02.013_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/joco.joco_113_21","article-title":"Five-year experience in treatment of retinoblastoma with intra-arterial chemotherapy: a single-center analysis","volume":"33","author":"Ghassemi","year":"2021","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.855661","article-title":"Intra-arterial chemotherapy as primary treatment for advanced unilateral retinoblastoma in China","volume":"9","author":"Liang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.oret.2025.02.013_bib11","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.jaapos.2020.12.006","article-title":"Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex","volume":"25","author":"Shields","year":"2021","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.oret.2025.02.013_bib12","first-page":"500","article-title":"Intra-arterial chemotherapy for retinoblastoma: 15-year experience","volume":"241","author":"Stathopoulos","year":"2023","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.oret.2025.02.013_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000500010","article-title":"Intra-arterial chemotherapy for retinoblastoma: four-year results from tertiary center in India","volume":"6","author":"Rishi","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.oret.2025.02.013_bib14","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.radcr.2022.09.004","article-title":"Intra-arterial chemotherapy for retinoblastoma: our first experience in Indonesia","volume":"17","author":"Sidipratomo","year":"2022","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.oret.2025.02.013_bib15","article-title":"Intra-arterial chemotherapy for retinoblastoma: our first three-and-a-half years\u2019 experience in Malaysia","volume":"15","author":"Liu","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/IJO.IJO_227_23","article-title":"Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries \u2013 can we break the barriers?","volume":"71","author":"Honavar","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197081","article-title":"Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival","volume":"13","author":"Francis","year":"2018","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30352","article-title":"How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: a consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP)","volume":"70","author":"Garin","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.oret.2025.02.013_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.oret.2025.02.013_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.oret.2025.02.013_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.oret.2025.02.013_bib22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13816810.2016.1244695","article-title":"Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma","volume":"38","author":"Abramson","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2025.02.013_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034120","article-title":"Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review","volume":"7","author":"Abramson","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12885-018-4406-6","article-title":"Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.oret.2025.02.013_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156806","article-title":"Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy)","volume":"11","author":"Abramson","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.02.013_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neo.2018.05.007","article-title":"Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy","volume":"20","author":"Francis","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.oret.2025.02.013_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3928\/01913913-20160719-04","article-title":"Retinoblastoma control with primary intra-arterial chemotherapy: outcomes before and during the intravitreal chemotherapy era","volume":"53","author":"Shields","year":"2016","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.oret.2025.02.013_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/APO.0000000000000172","article-title":"Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma","volume":"5","author":"Shields","year":"2016","journal-title":"Asia-Pac J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3174\/ajnr.A4741","article-title":"Hemodynamic and anatomic variations require an adaptable approach during intra-arterial chemotherapy for intraocular retinoblastoma: alternative routes, strategies, and follow-up","volume":"37","author":"Bertelli","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.oret.2025.02.013_bib33","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3174\/ajnr.A3019","article-title":"Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization","volume":"33","author":"Klufas","year":"2012","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.oret.2025.02.013_bib34","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1097\/IAE.0000000000002315","article-title":"Ophthalmic vascular events after intra-arterial chemotherapy for retinoblastoma: real-world comparison between primary and secondary treatments","volume":"39","author":"Ancona-Lezama","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.013_bib35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ophtha.2018.05.013","article-title":"Ophthalmic vascular events after primary unilateral intra-arterial chemotherapy for retinoblastoma in early and recent eras","volume":"125","author":"Dalvin","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.013_bib36","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/bjophthalmol-2018-312915","article-title":"Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007\u20132017","volume":"103","author":"Lu","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.013_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ophtha.2022.04.022","article-title":"Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.013_bib38","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-19-1262","article-title":"Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival","volume":"18","author":"Xu","year":"2020","journal-title":"Mol Cancer Res"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302500065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302500065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:06:10Z","timestamp":1754035570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302500065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S246865302500065X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.02.013","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00c2\u00a9 2025 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}